The Empire State Building Celebrates Romance in NYC with Valentine’s Day Experiences Throughout the Month of February
7.2.2023 18:56:00 EET | Business Wire | Press release
Love is in the air at the Empire State Building (ESB) with a Valentine’s Day celebration that includes an unforgettable proposal package, tower lighting, giveaways, and month-long special offers for visitors this February.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230207005876/en/
Empire State Building Valentine's Day 86th Floor Observatory (Photo: Business Wire)
- Happily Ever Empire – Each couple that books the popular Happily Ever Empire engagement package – that includes priority access and a private tour of the Observatory with celebratory champagne – for Feb. 10-14 will be gifted a four-night, five-day luxury all-inclusive getaway by Sandals Resorts to the resort of their choice (terms and conditions apply) – that includes the brand new Sandals Dunn’s River that opens in Ocho Rios, Jamaica in May – and a $250 gift card towards a wedding dress courtesy of Kleinfeld Bridal. Happily Ever Empire engagement packages are limited to five bookings per day.
- Getaway Giveaway – Visitors to the Observatory Experience from Feb. 10-14 can enter to win a four-night, five-day all-inclusive resort stay courtesy of Sandals Resorts when they post a photo from the special Valentine’s Day photo corner on the 86th Floor Observatory and tag @sandalsresorts on Instagram.
- Spread the Love – All visitors who purchase tickets on the ESB website during the month of February will receive 10 percent off online orders from Magnolia Bakery, 25 percent off Valentine’s Day flowers from FTD Flowers, and 20 percent off online orders from Tony’s Chocolonely from Feb. 6-14. On Feb. 11 from 2-8 pm, Tony’s Chocolonely will show love with free chocolate heart samples on the 86th Floor Observatory.
- Love Lights – On Feb. 14, the Empire State Building’s world-famous tower lights will shine in a pink heartbeat as a Valentine’s Day gift to New York City.
“The reimagined Observatory at the World’s Most Romantic Building draws visitors from around the world for an authentic experience in the heart of New York City,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “Our remarkable views provide visitors with the perfect backdrop for an over-the-top date or proposal.”
“It’s the season of romance and as a brand founded on all things love, Sandals Resorts is here to remind couples of the importance of celebrating love,” said Luisana Suegart, director of public relations for the worldwide representatives of Sandals Resorts. “Recent studies from our Institute of Romance found that a key ingredient in thriving relationships is making the time for connection, with couples feeling closest to each other while on vacation and, forget the chocolates, most agreeing that a getaway is the most romantic gift. Gifting these special couples an idyllic Caribbean escape is our way of celebrating such an important milestone.”
Hi-res imagery and b-roll of the Empire State Building, the scheduled Valentine’s Day tower lighting and all the upcoming exclusive offerings can be downloaded here .
More information about the Empire State Building Observatory can be found online.
About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. Learn more at www.esbnyc.com. Declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 Attraction in the United States in Tripadvisor’s 2022 Travelers’ Choice Best of the Best, and the #1 New York City attraction by Lonely Planet, it welcomes more than 4 million annual visitors from around the world.
Since 2011, the building has been fully powered by renewable wind electricity, and its many floors primarily house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, Twitter, Instagram, Weibo, YouTube, or TikTok.
Source: Empire State Realty Trust, Inc.
Category: Observatory
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230207005876/en/
Contact information
MEDIA:
Empire State Realty Trust
Brock Talbot
347-804-7863
btalbot@esrtreit.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
